SAN DIEGO, CALIFORNIA, APRIL 2025—iCFO Venture Group, LLC, a subsidiary of iCFO Capital Global, Inc., is excited to announce its partnership with Harvard MedTech through the iCFO Capital Global Special Purpose Vehicle (SPV) program.
Harvard MedTech (HMT) is a commercial-stage healthcare company delivering an innovative, clinically validated solution for chronic pain and behavioral health through its Vx Therapy platform. Combining immersive virtual reality therapy with behavioral health clinician support, HMT effectively addresses trauma-related conditions such as pain, depression, anxiety, PTSD, and sleep disorders.
Unlike conventional interventions, which are often costly and insufficient, HMT offers a reimbursable, FDA-registered alternative with a pragmatic go-to-market strategy and proven traction across multiple healthcare verticals.
Shan is the founder and CEO of Harvard MedTech. Shan is a serial entrepreneur who has founded, scaled, and sold three healthcare companies prior to Harvard MedTech. Two of them were medical device companies and the third a technology-enabled services company.
One of his medical device companies did a successful IPO on Nasdaq prior to eventually being sold to a strategic acquirer. Shan was named to the Chicagoland Entrepreneurial Hall of Fame and was chosen as the KPMG High Tech Entrepreneur of the year for Illinois in 1998. He is a former member of the World Economic Forum and a current member of YPO.
Shan earned a Bachelor’s degree from Harvard University with a major in Biology.
For more information about the company, please visit: https://harvardmedtech.com/
iCFO Capital Global, Inc. provides a platform for Entrepreneurs to connect with our Private Investors that makes direct debt and equity investment for early-stage and expand growth businesses. To learn more about how your business can secure the funding it needs, visit: https://www.icfocapital.com/
Media disclaimer: “Information herein is for general information purposes only. No offer or solicitation of securities is made or implied.”
This communication is intended for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities. Any securities offering will be made only pursuant to an exemption from registration under the Securities Act of 1933, including Regulation D, and only to accredited investors. iCFO Capital Global is not a registered broker-dealer and does not provide transaction-based compensation or investment advisory services.